Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Opzelura
Pharma
Sun Pharma beats Incyte in appeals, teeing up US alopecia launch
In a win against autoimmune rival Incyte, a U.S. appeals court has tossed an injunction blocking Sun Pharma from launching its alopecia med Leqselvi.
Fraiser Kansteiner
Apr 10, 2025 10:00am
Incyte posts mixed Opzelura results in prurigo nodularis
Mar 10, 2025 11:23am
Incyte provides first guidance for JAK cream Opzelura
Feb 10, 2025 2:25pm
Incyte eyes upcoming launches as Jakafi's patent cliff nears
Oct 29, 2024 5:07pm
Incyte picks Dr. Pimple Popper to expand Opzelura campaign
Oct 14, 2024 10:23am
Incyte finds fun in pharma ad fatigue in Opzelura TV spot
Aug 6, 2024 6:45am
